References
- Peragallo JH. Pediatric Myasthenia Gravis. Semin Pediatr Neurol. 2017; 24(2):116-121.
- Kliegman R. Nelson textbook of pediatrics, 21st edition. Elsevier, Philadelphia, PA; 2020.
- Iijima S. Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis. Pediatr Neonatol. 2021; 62(6):581-590.
- McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology. 2010; 34(3):171-83.
- Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010 Jun 18; 10:46.
- Niks EH, et al. A transient neonatal myasthenic syndrome with anti-musk antibodies. Neurology. 2008; 70:1215-1216.
- Drachman DB. Myasthenia gravis. The New England Journal of Medicine. 1994; 330:1797-1810.
- Sisman J, Ceri A, Nafday SM. Seronegative neonatal myasthenia gravis in one of the twins. Indian Pediatr 2004; 41(9):938–40.
- Qi QW, Wang D, Liu JT, Bian XM. Management of pregnancy with myasthenia gravis: 7 cases report. Zhonghua Fu Chan Ke Za Zhi. 2012; 47:241-244.
- Bardhan M, Dogra H, Samanta D. Neonatal Myasthenia Gravis. [Updated 2022 Feb 4]. In: Stat-Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.uptodate.com
- Papazian O: Transient neonatal myasthenia gravis. J Child Neurol 1992, 7(2):135-141.
- Polizzi A, Huson SM, Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology. 2000; 62(5):332-41.
- Gardnerova M, et al. The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology 1997, 48(1):50-54.
- Santiago Gonçalves C, Nunes Marques MI, Antunes S, Serrano A. Transient Neonatal Myasthenia Gravis: A Case Report. Cureus. 2021; 13(12):e20592.
- Dhugga L, Geethanath R, Onwuneme C. Transient neonatal myasthenia gravis following maternal myasthenia gravis presenting in pregnancy after treatment with Alemtuzumab. Case Report in Perinatal Medicine. 2020; 9(1): 20200065.
- Bardhan M, Dogra H, Samanta D: Neonatal myasthenia gravis. StatPearls Publishing, Treasure Island, FL; 2020.
- Rodriguez M, Gomez MR, Howard FM, Taylor WF. Myasthenia gravis in children: long-term follow-up. Ann Neurol. 1983; 13(5):504-10.
- Elsais A, Popperud TH, Melien Ø, Kerty E. Drugs that may trigger or exacerbate myasthenia gravis. Tidsskrift for den Norske Lægeforening. 2013; 133:296-299.
- Bassan H, Muhlbaur B, Tomer A, Spirer Z. High-dose intravenous immunoglobin in transient neonatal myasthenia gravis. Pediatr Neurol 1998; 18: 181e3.
- Tagher RJ, Baumann R, Desai N. Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis. J Pediatr 1999; 134:233e5.
- Namba T, Brown SB, Grob D. Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics 1970; 45:488e504.
- Hassoun M, El Turjuman U, Chokr I, Fakhoury H: Myasthenia gravis in the neonate. Neoreviews. 2020, 11:200-5.
- Bartoccioni E, et al. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. J Neuroimmunol. 1986; 12(2):155-61.